Literature DB >> 434678

Disseminated intravascular coagulation with the peritoneovenous shunt.

D C Harmon, Z Demirjian, L Ellman, J E Fischer.   

Abstract

Coagulation data were collected before and after peritoneovenous shunting for intractable ascites in 19 shunting procedures. After insertion of the shunts, changes consistent with disseminated intravascular coagulation developed in all cases in which good flow of ascitic fluid was obtained. In cases with temporary shunt function, the coagulation variables suggestive of disseminated intravascular coagulation returned toward normal when the flow of ascitic fluid ceased. A fall in the level of fibrinogen degradation products indicated that the shunt had clotted. Bleeding attributable to disseminated intravascular coagulation alone was uncommon. Clotting of the shunts was frequent. The use of heparin improved some of the coagulation variables but did not prevent shunt clotting or clinical bleeding. We conclude that the peritoneovenous shunt induces a moderate disseminated intravascular coagulation and that measurement of fibrinogen degradation products is useful in assessing shunt function.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 434678     DOI: 10.7326/0003-4819-90-5-774

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  13 in total

Review 1.  Haemostatic problems in liver disease.

Authors:  D A Kelly; E G Tuddenham
Journal:  Gut       Date:  1986-03       Impact factor: 23.059

2.  Refractory ascites associated with polycystic liver disease. Treatment with peritoneovenous shunt.

Authors:  T J McGarrity; K L Koch; D A Rasbach
Journal:  Dig Dis Sci       Date:  1986-02       Impact factor: 3.199

Review 3.  [Peritoneovenous shunt in the treatment of therapy-refractory ascites].

Authors:  C A Eriksen; A Cuschieri
Journal:  Langenbecks Arch Chir       Date:  1988

4.  Coagulopathy post peritoneovenous shunt.

Authors:  H H LeVeen; M Ip; N Ahmed; R B Hutto; E G LeVeen
Journal:  Ann Surg       Date:  1987-03       Impact factor: 12.969

5.  Morbidity and mortality after peritoneovenous shunt surgery for refractory ascites.

Authors:  D Rubinstein; I McInnes; F Dudley
Journal:  Gut       Date:  1985-10       Impact factor: 23.059

6.  The LeVeen shunt in the elective treatment of intractable ascites in cirrhosis. A prospective study on 140 patients.

Authors:  C Smadja; D Franco
Journal:  Ann Surg       Date:  1985-04       Impact factor: 12.969

7.  Ascites-induced LeVeen shunt coagulopathy.

Authors:  M V Ragni; J H Lewis; J A Spero
Journal:  Ann Surg       Date:  1983-07       Impact factor: 12.969

Review 8.  Role of surgical therapy in management of intractable ascites.

Authors:  J Elcheroth; C Vons; D Franco
Journal:  World J Surg       Date:  1994 Mar-Apr       Impact factor: 3.352

9.  Coagulopathy of peritoneovenous shunts: studies on the pathogenic role of ascitic fluid collagen and value of antiplatelet therapy.

Authors:  H H Salem; F J Dudley; A Merrett; J Perkin; B G Firkin
Journal:  Gut       Date:  1983-05       Impact factor: 23.059

10.  Peritoneovenous shunts for palliation of the patient with malignant ascites.

Authors:  D L Schumacher; T J Saclarides; E D Staren
Journal:  Ann Surg Oncol       Date:  1994-09       Impact factor: 5.344

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.